itanapraced (CHF-5074) / Chiesi, CereSpir  >>  Phase 1
Welcome,         Profile    Billing    Logout  

3 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
itanapraced (CHF-5074) / CereSpir
CT01, NCT00954252: Safety, Pharmacokinetics and Pharmacodynamics Study of Treatment With CHF 5074 in Healthy Young Male Subjects

Completed
1
84
US
CHF 5074, placebo
CERESPIR
Alzheimer's Disease
05/10
05/10
CT02, NCT01203384: Study to Evaluate Safety, Pharmacokinetics and Pharmacodynamics of CHF5074 in Healthy Young Male Subjects

Completed
1
48
US
CHF5074 1x, CHF5074 2x, CHF5074 3x, Placebo
CERESPIR
Alzheimer's Disease
12/10
12/10
CT03, NCT01258452: Study to Evaluate the Effects of Food Ingestion on the Pharmacokinetics of CHF 5074 in Healthy Young Male Subjects

Completed
1
12
US
CHF 5074, CHF 5974
CERESPIR
Alzheimer's Disease
03/11
03/11

Download Options